Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - SEELOS THERAPEUTICS, INC. | apri12312014ex321.htm |
| EX-10.27 - EXHIBIT 10.27 - SEELOS THERAPEUTICS, INC. | apri12312014ex1027.htm |
| EX-31.1 - EXHIBIT 31.1 - SEELOS THERAPEUTICS, INC. | apri12312014ex311.htm |
| EX-21 - EXHIBIT 21 - SEELOS THERAPEUTICS, INC. | apri12312014ex21.htm |
| EX-32.2 - EXHIBIT 32.2 - SEELOS THERAPEUTICS, INC. | apri12312014ex322.htm |
| EX-31.2 - EXHIBIT 31.2 - SEELOS THERAPEUTICS, INC. | apri12312014ex312.htm |
| EX-10.28 - EXHIBIT 10.28 - SEELOS THERAPEUTICS, INC. | apri12312014ex1028.htm |
| EX-10.26 - EXHIBIT 10.26 - SEELOS THERAPEUTICS, INC. | apri12312014ex1026.htm |
| EXCEL - IDEA: XBRL DOCUMENT - SEELOS THERAPEUTICS, INC. | Financial_Report.xls |
| 10-K - 10-K - SEELOS THERAPEUTICS, INC. | apri12312014.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-3 (Nos. 333-200799, 333-198066, 333-191679, 333-182703, 333-148060, 333-107137, 333-122114, 333-117717, 333-125565, 333-140110, 333-152591, 333-132611, 333-111894, 333-105509, 333-165958, 333-178592, 333-96813, 333-46967 and 333-91957) and Forms S-8 (Nos. 333-191680, 333-182704, 333-152284, 333-138598, 333-174392, 333-167365 and 333-93435) of Apricus Biosciences, Inc. of our report dated March 16, 2015, relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP |
San Diego, CA |
March 16, 2015 |